home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A True Believer Dismisses Indifference to Bioinformatics (Washington Post)

  March, 14 2002 18:55
your information resource in human molecular genetics
Bioinformatics -- the marriage of biology and information technology -- is changing the way scientists study disease and develop medicines, replacing hours of tedious laboratory work with a few mouse clicks.

But bioinformatics companies, which captured Wall Street's imagination in the late 1990s, are losing their luster with investors. For instance, shares of InforMax Inc., a Bethesda software maker, are trading near their all-time low.

Yet Stephen E. Lincoln, InforMax's chief scientific officer, is as bullish as ever on the future of the industry.

Full story can be found in the Washington Post, March 14, 2002.

Message posted by: Anthony W.I. Lo

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.